E-therapeutics Share Discussion Threads

[beaufort1] 15/2/2011 14:39

Quite a big punt by Invesco - I wonder if Neil Woodford is behind this. it virtually amounts to a takeover

[beaufort1] 15/2/2011 09:13

Well that's interesting and quite a vote of confidence in the drugs pipeline.

[aim_trader] 15/2/2011 08:38

E-Therapeutics raises £17.6 mln to develop four lead drug candidates

[ceohunter] 15/10/2010 12:49

Click here for ETX's presentation from last night's Proactive Investors Event:

[ceohunter] 12/10/2010 09:00

UPDATE:

The directors of e-Therapeutics (AIM: ETX), Advanced Cell Technology (OTCBB: ACTC), Kiotech International (AIM: KIO) and Camco International (AIM: CAO) will be presenting on Thursday 14th October 2010 at the Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB.

The presentations will start at 6:00pm and finish at approx 8:00pm. After the presentations are complete the directors will also be available to take questions during a free canapé and wine reception.

CLICK HERE TO REGISTER YOUR ATTENDANCE:

[dynamic2005] 10/10/2010 20:27

"OUTSIDERS: Newcastle-based E-Therapeutics has a database of molecules that can be searched and matched to create a supposedly 'less risky' drug development path - Google-biotech, if you will."

[ceohunter] 01/10/2010 14:40

The directors of e-Therapeutics plc (AIM: ETX), Advanced Cell Technology (OTCBB: ACTC) and Kiotech International (AIM: KIO) will be presenting on:
Thursday the 14th October 2010
at the:
Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB

The presentations will start at 6:00pm and finish at approx 7:30pm. After the presentations are complete the directors will also be available to take questions during a free canapé and wine reception.

[beaufort1] 30/9/2010 11:59

Had rather given up on this one, so good to see faint signs of life.

[dynamic2005] 30/9/2010 10:58

30-09-10 Panmure Gordon Buy Recommendation (New Coverage) : Target Price 80p : Upside 152%

Made a small investment at 31.75 today as the future looks a lot more promising after the RNS last week which makes it a more attractive target over next 6-12 months.

Good luck all.

[dynoport] 13/9/2010 18:42

Is he saying that some more fundraising might be needed and that the USA is where it might take place with a placing on nasdaq?

[dynoport] 13/9/2010 10:46

Thanks for that, very interesting.

[aim_trader] 13/9/2010 09:45

e-Therapeutics Phase II drugs could have a £1bln potential value for the company

Monday, September 13,

2010 Malcolm Young, CEO of e-Therapeutics talks to Proactive Investors on the potential value of drugs in Phase II of the pipeline and that there's a disconnect between the share price and the value of the science owned by the company. He says, in general terms, there's a better understanding of biotech companies in the US than there is in the UK, an obvious reason to keep an eye on the US markets.

[trusty] 06/3/2010 21:13

Cornhill Asset Management

[investinggarden] 02/3/2010 11:47

Speculative Buy rating from Growth Company Investor

[beaufort1] 24/2/2010 17:48

Who or what is CAM?

[trusty] 17/2/2010 17:14

coverage about to start at CAM

[beaufort1] 15/2/2010 10:10

Well an RNS at last.

[beaufort1] 03/11/2009 13:52

Excellent - very narrow discount to existing share price Prospects must be very good

[ianbrewster] 03/11/2009 12:08

e-Therapeutics plc
("e-Therapeutics" or the "Company")
Placing

e-Therapeutics plc (AIM: ETX), the network-based drug discovery company, today
is pleased to announce that it has conditionally placed 6,541,000 new Ordinary
Shares of 0.1p each in the Company (the "Placing Shares") with a new
institutional shareholder to raise approximately GBP2.5 million before expenses
(the "Placing").

The Placing has been completed at a price of 38p per Placing Share (the "Placing Price") representing a discount of approximately 11.6 per cent. to the closing mid-market price per ordinary share on 30 October 2009.

The Placing Shares will represent approximately 10 per cent of the Company's
enlarged issued ordinary share capital following the Placing and will rank pari
passu in all respects with the existing Ordinary Shares in the Company.

Purpose of the Fundraising
The Fundraising provides e-Therapeutics with working capital to continue ongoing discovery and development activities.

The costs of operating e-Therapeutics remain modest compared to conventional
biotechnology companies. This low cost model is anticipated to continue and,
together with the initiatives outlined below for candidate development
financing, allows value to be created efficiently for shareholders.
The strategy of the Company remains the discovery and development of a portfolio of candidates each of which is assessed to have unique medical attributes addressing, what the directors believe to be commercially significant unmet medical need. These candidates are planned for development and launch in major pharmaceutical markets after 2012 when the industry's patent expiry and productivity problems are expected to create considerable demand and value for such candidates.

Admission
The Placing is conditional on, inter alia, admission of the Placing Shares to
trading on AIM. Application is being made to admit the Placing Shares to trading on AIM and dealings in the Placing Shares are expected to commence on or around 6 November 2009.

Accordingly, at the close of business on 02 November 2009, the Company will have in issue 65,420,292 ordinary shares of 0.1p with voting rights. No ordinary shares are held in Treasury.

[beaufort1] 27/10/2009 16:06

SP now steaming ahead!!

[maxk] 17/8/2009 20:24

You might want to look into the buying positions of the various stakeholders, because there may be a problem with using stronger/different approach intibiotics in general, as the bugs simply comeback stronger.

I do not hold, and have no interest except in bug treatment generally.

[aldridge] 17/8/2009 19:10

So whats driving the 30% price increase over the last month or so. Has someone woken up to their drugs pipeline and business model?

[investinggarden] 05/8/2009 12:18

Time to bag biotech bargains

[aldridge] 03/8/2009 21:37

who bought 1.4m shares I wonder.May be a declarable purchase